Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seliger

Showing results (241-250 of 304) with videos related to

Pageof 31
Sort By:
Cancer Research|September 6, 2005
Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survivalYuanmei Lou, Timothy Z Vitalis, Genc Basha, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2025
Perspectives on the role of "-Omics" in predicting response to immunotherapyAnna Maria Di Giacomo, Sumit Subudhi, Wim Vos, et al.
Cancer Immunology, Immunotherapy : CII|February 14, 2009
The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanomaHildur Helgadottir, Emilia Andersson, Lisa Villabona, et al.
Oncoimmunology|July 9, 2015
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinomaSimon Jasinski-Bergner, Christine Stoehr, Juergen Bukur, et al.
Frontiers in Oncology|May 10, 2021
Endogenous Retroviral-K Envelope Is a Novel Tumor Antigen and Prognostic Indicator of Renal Cell CarcinomaVeronika Weyerer, Pamela L Strissel, Christine Stöhr, et al.
Frontiers in Immunology|October 29, 2024
HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevanceAnnalena Branz, Christian Matek, Fabienne Lange, et al.
Cellular and Molecular Life Sciences : CMLS|December 3, 2024
Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumorsKarthikeyan Subbarayan, Ahmed Al-Samadi, Helene Schäfer, et al.
Proteomics|July 2, 2003
Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapyBarbara Seliger, Matthias Menig, Rudolf Lichtenfels, et al.
Proteomics|October 20, 2010
Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model systemStefania Croci, Christian V Recktenwald, Rudolf Lichtenfels, et al.
Cancer Immunology Research|January 6, 2018
T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell TherapyRikke Andersen, Marie Christine Wulff Westergaard, Julie Westerlin Kjeldsen, et al.
Pageof 31

Showing results (241-250 of 304) with videos related to

Sort By:
Pageof 31
Cancer Research|September 6, 2005
Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survivalYuanmei Lou, Timothy Z Vitalis, Genc Basha, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2025
Perspectives on the role of "-Omics" in predicting response to immunotherapyAnna Maria Di Giacomo, Sumit Subudhi, Wim Vos, et al.
Cancer Immunology, Immunotherapy : CII|February 14, 2009
The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanomaHildur Helgadottir, Emilia Andersson, Lisa Villabona, et al.
Oncoimmunology|July 9, 2015
Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinomaSimon Jasinski-Bergner, Christine Stoehr, Juergen Bukur, et al.
Frontiers in Oncology|May 10, 2021
Endogenous Retroviral-K Envelope Is a Novel Tumor Antigen and Prognostic Indicator of Renal Cell CarcinomaVeronika Weyerer, Pamela L Strissel, Christine Stöhr, et al.
Frontiers in Immunology|October 29, 2024
HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevanceAnnalena Branz, Christian Matek, Fabienne Lange, et al.
Cellular and Molecular Life Sciences : CMLS|December 3, 2024
Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumorsKarthikeyan Subbarayan, Ahmed Al-Samadi, Helene Schäfer, et al.
Proteomics|July 2, 2003
Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapyBarbara Seliger, Matthias Menig, Rudolf Lichtenfels, et al.
Proteomics|October 20, 2010
Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model systemStefania Croci, Christian V Recktenwald, Rudolf Lichtenfels, et al.
Cancer Immunology Research|January 6, 2018
T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell TherapyRikke Andersen, Marie Christine Wulff Westergaard, Julie Westerlin Kjeldsen, et al.
Pageof 31